Opportunities offered by recombinant antibody technology
our 15-year experience with nanobodies
Abstract
Opportunities offered by recombinant antibody technology: our 15-year experience with nanobodies
Keywords
nanobodies;diagnostics;in vitro selection;
Data
| Language: | English |
|---|---|
| Year of publishing: | 2020 |
| Typology: | 3.14 - Invited Lecture at Foreign University |
| Organization: | UNG - University of Nova Gorica |
| UDC: | 577.2 |
| COBISS: |
5577979
|
| Views: | 2062 |
| Downloads: | 0 |
| Average score: | 0 (0 votes) |
| Metadata: |
|
Other data
| URN: | URN:SI:UNG |
|---|---|
| Type (COBISS): | Not categorized |
| ID: | 11419656 |
Recommended works:
Opportunities offered by recombinant antibody technology
2020,
our 15-year experience with nanobodies
Nanobodies
2018,
ǂa ǂflexible technological platform
Nanobodies
2017,
towards rational design of immune-reagents
Nanobodies for research & clinical applications
2016,
lecture at the Faculty of Chemistry, University of Belgrade, 22. 9. 2016
Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs
2015,
no subtitle data available